VitaPath Genetics
Foster City
About VitaPath Genetics
VitaPath Genetics is developing a family of DNA tests to help individuals reduce the risk of serious and life-threatening disease. Their first product is a genetic test to identify risk factors that are associated with a common birth defect called Spina Bifida and which can be safely corrected with low-risk vitamin supplementation under the care of a physician.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $15.2M
- Funding stage: Late Stage Venture
- Last round: Series C (Aug 2012)
- Website: vpgenetics.com
- Phone: + 16506381790
Industries & Categories
Biotechnology, Genetics, Health Care, Medical
Canonical: https://fsome.com/organization/vitapath-genetics-1879514 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.